New Zealand markets closed

ResMed Inc. (RMD)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
217.75-0.40 (-0.18%)
As of 01:32PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 32.05B
Enterprise value 32.98B
Trailing P/E 33.56
Forward P/E 25.91
PEG ratio (5-yr expected) 1.92
Price/sales (ttm)7.02
Price/book (mrq)6.92
Enterprise value/revenue 7.19
Enterprise value/EBITDA 21.90

Trading information

Stock price history

Beta (5Y monthly) 0.67
52-week change 3-5.83%
S&P500 52-week change 322.43%
52-week high 3237.26
52-week low 3132.24
50-day moving average 3189.56
200-day moving average 3172.26

Share statistics

Avg vol (3-month) 31.12M
Avg vol (10-day) 31.64M
Shares outstanding 5146.91M
Implied shares outstanding 6146.91M
Float 8145.47M
% held by insiders 10.82%
% held by institutions 159.20%
Shares short (15 Apr 2024) 47.95M
Short ratio (15 Apr 2024) 47.89
Short % of float (15 Apr 2024) 46.17%
Short % of shares outstanding (15 Apr 2024) 45.41%
Shares short (prior month 15 Mar 2024) 47.66M

Dividends & splits

Forward annual dividend rate 41.92
Forward annual dividend yield 40.88%
Trailing annual dividend rate 31.88
Trailing annual dividend yield 30.86%
5-year average dividend yield 40.87
Payout ratio 428.92%
Dividend date 313 Jun 2024
Ex-dividend date 408 May 2024
Last split factor 22:1
Last split date 331 Aug 2010

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2021
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 20.91%
Operating margin (ttm)31.29%

Management effectiveness

Return on assets (ttm)11.91%
Return on equity (ttm)22.39%

Income statement

Revenue (ttm)4.58B
Revenue per share (ttm)31.17
Quarterly revenue growth (yoy)7.20%
Gross profit (ttm)N/A
EBITDA 1.44B
Net income avi to common (ttm)958.38M
Diluted EPS (ttm)6.50
Quarterly earnings growth (yoy)29.20%

Balance sheet

Total cash (mrq)259.45M
Total cash per share (mrq)1.77
Total debt (mrq)1.17B
Total debt/equity (mrq)25.21%
Current ratio (mrq)3.04
Book value per share (mrq)31.52

Cash flow statement

Operating cash flow (ttm)1.2B
Levered free cash flow (ttm)955.85M